Clinical Focus

  • Cancer > Hematology
  • Hematology

Academic Appointments

Professional Education

  • Medical Education: Icahn School of Medicine at Mount Sinai (1987) NY
  • Residency: Harbor UCLA Internal Medicine Residency (1990) CA
  • Internship: Harbor UCLA Internal Medicine Residency (1988) CA
  • Fellowship: University of Rochester Hematology and Oncology Fellowship (1996) NY
  • Fellowship: University of Rochester Hematology and Oncology Fellowship (1994) NY
  • Board Certification: American Board of Internal Medicine, Internal Medicine (1990)
  • Board Certification: American Board of Internal Medicine, Medical Oncology (1995)
  • Board Certification: American Board of Internal Medicine, Hematology (1994)

Contact

  • Academic
    University - Academic staff Department: Medicine - Med/Hematology Position: Clinical Assistant Professor
  • Clinical Stanford Cancer Center 875 Blake Wilbur Dr Rm 2223 MC 6560 Stanford, CA 94305 (650) 724-5203 (fax)

Additional Info

  • Other Names:
    Beth A Martin-Kool

All Publications

  • High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies MUSCLE & NERVE Lin, P. T., Martin, B. A., Weinacker, A. B., So, Y. T. 2006; 33 (3): 433-435

    Abstract

    We describe a 48-year-old woman with seronegative myasthenia gravis (MG) and high-titer of anti-MuSK antibody. She had severe bulbar and respiratory weakness with minimal limb weakness for 2 years. Her disease responded poorly to all the conventional immunosuppressive regimens. Treatment with immunoablative dose of cyclophosphamide led to dramatic and sustained remission of her symptoms. High-dose cyclophosphamide is an effective alternative in patients with unusually refractory disease.

    View details for DOI 10.1002/mus.20411

    View details for PubMedID 16116645